Other Income	6 Months Ended
Jun. 30, 2011
Other Income [Abstract]
OTHER INCOME	10. OTHER INCOME During April 2005, the Company discontinued all operations associated with its DIFOTI^{^®}product in order to focus its resources and attention on the development and commercialization of MelaFind^®. During December 2006, the Company entered into a sale and exclusive licensing agreement with KaVo Dental GmbH (“KaVo”), a leading dental equipment manufacturer, which provides for KaVo to further develop and commercialize DIFOTI^®. Since July 2008, KaVo has been required to pay to the Company a royalty stream based upon the worldwide aggregate net sales of the licensed product, as defined in the license agreement, or a set minimum. For the three and six months ended June 30, 2011, the Company earned royalty income of $5 and $10, respectively. For the three and six months ended June 30, 2010, the Company was paid royalty income of $5 and $10, respectively.

Other Income

6 Months Ended

Jun. 30, 2011

10. OTHER INCOME

During April 2005, the Company discontinued all operations associated with its DIFOTI^{^®}product in order to focus its resources and attention on the development and commercialization of MelaFind^®. During December 2006, the Company entered into a sale and exclusive licensing agreement with KaVo Dental GmbH (“KaVo”), a leading dental equipment manufacturer, which provides for KaVo to further develop and commercialize DIFOTI^®. Since July 2008, KaVo has been required to pay to the Company a royalty stream based upon the worldwide aggregate net sales of the licensed product, as defined in the license agreement, or a set minimum. For the three and six months ended June 30, 2011, the Company earned royalty income of $5 and $10, respectively. For the three and six months ended June 30, 2010, the Company was paid royalty income of $5 and $10, respectively.